Escherichia coli has been the organism of choice for the production of different chemicals by engineering native and heterologous pathways. In the present study, we simultaneously address some of the main issues associated with E. coli as an industrial platform for isoprenoids, including an inability to grow on sucrose, a lack of endogenous control over toxic mevalonate (MVA) pathway intermediates, and the limited pathway engineering into the chromosome. As a proof of concept, we generated an E. coli DH1 strain able to produce the isoprenoid bisabolene from sucrose by integrating the cscAKB operon into the chromosome and by expressing a heterologous MVA pathway under stress-responsive control. Production levels dropped dramatically relative to plasmid-mediated expression when the entire pathway was integrated into the chromosome. In order to optimize the chromosomally integrated MVA pathway, we established a CRISPR-Cas9 system to rapidly and systematically replace promoter sequences. This strategy led to higher pathway expression and a 5-fold improvement in bisabolene production. More interestingly, we analyzed proteomics data sets to understand and address some of the challenges associated with metabolic engineering of the chromosomally integrated pathway. This report shows that integrating plasmid-optimized operons into the genome and making them work optimally is not a straightforward task and any poor engineering choices on the chromosome may lead to cell death rather than just resulting in low titers. Based on these results, we also propose directions for chromosomal metabolic engineering. This article is protected by copyright. All rights reserved
Introduction
Bio-based production of fuels and chemicals makes use of cheap, renewable carbon sources to synthesize molecules that the traditional chemical industry manufactures from fossil resources. Increasing costs and volatility of petroleum prices, in combination with substantial improvements in biotechnology, have stimulated the use of microbial production systems for fuels and chemicals (Keasling et al., 2012) . Advances in synthetic biology in the last two decades (Cameron et al., 2014) have enabled the engineering of microbial hosts able to transform renewable feedstocks into valuable products ranging from drugs (Ajikumar et al., 2010; Paddon et al., 2013) and commodity chemicals (Yim et al., 2011) to biofuels (Atsumi et al., 2008; Bokinsky et al., 2011; Dellomonaco et al., 2011; Steen et al., 2010) .
Industrial microbial production of high-volume, low cost chemicals and fuels, however, requires very high efficiency in order to compete with the petroleum-based counterparts (Meadows et al., 2016) . The efficiency of a bioprocess is defined by the microbial host ability to transform cheap carbon sources into valuable molecules at high titers, rates and yields. Industry is therefore constantly looking for faster ways to engineer these capabilities in order to reduce production costs and maximize the profit. The following five host characteristics would be keys to bring a microbe closer to industrial application: i) deep understanding of the host metabolism, ii) availability of genetic tools, iii) capacity to grow on inexpensive carbon sources with a short doubling time, iv) an autonomous, inducer-free expression system that doesn't allow accumulation of toxic metabolites, and v) chromosomally integrated pathway operons to avoid genetic instability and the use of expensive antibiotics required to maintain plasmids.
The two most popular microbial hosts for industrial production are the model eukaryote, baker's yeast (Saccharomyces cerevisiae), and the model prokaryote, Escherichia coli (Westfall
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This article is protected by copyright. All rights reserved and Gardner, 2011), due to the plethora of tools and knowledge available for them. E. coli is possibly the most studied organism, and its advantages include: i) rapid doubling time, ii) the most diverse set of tools to control gene expression (promoters, expression vectors, etc) , iii) ease of engineering, iv) fully annotated genome, and v) detailed understanding of its metabolism. All these qualities have enabled extensive applications of engineered E. coli for industrial use Yim et al., 2011) , and made it the organism of choice by many leaders in the biotechnology field Steen et al., 2010; Westfall and Gardner, 2011) .
However, there are several issues to using E. coli as an industrial host, including i) susceptibility to phage contamination (Junker et al., 2006) , ii) inefficiency in growing on certain desirable carbon sources (especially sucrose), and iii) low recombination capacity of DNA into its chromosome (Jeong et al., 2013; Mosberg et al., 2010) . The first two issues have been previously addressed. Countermeasures for bacteriophage contamination have been developed (Los et al., 2004; Los et al., 2007) , and engineering approaches to introduce effective sucrose utilization capabilities are now available even though most industrial strains cannot grow on sucrose (Lee et al., 2010; Bruschi et al., 2011) . Feedstocks are the most expensive component of a bioprocess (Davis et al., 2013; Humbird et al., 2011) , and high feedstock cost severely hampers the economics of a bioprocess and its competitiveness with petroleum-based chemicals. Sucrose from sugarcane is a high purity and low energy input feedstock, and performs as well or better than lignocellulosics for greenhouse gas reduction, making it a preferred feedstock for industrial fermentation (Renouf et al., 2008; Klein-Marcuschamer et al., 2013) . Therefore, engineering sucrose utilization is an important feature for an industrial host.
Extensive research has proven the E. coli DH1 genotype suitable for the production of a myriad of isoprenoids as well as fatty acid-derived molecules at high titers (Alonso-Gutierrez et
This article is protected by copyright. All rights reserved George et al., 2015; Goh et al., 2014; Steen et al., 2010) . Dynamic control of expression of the MVA pathway has also been developed in this strain to circumvent endogenous control while allowing DH1 cells to sense their own environment and avoid accumulation of toxic intermediates (Dahl et al., 2013) ; this translates into better conversion efficiencies, avoids the need for expensive inducers, provides higher isoprenoid yields and improved strain stabilityall key features for industrial production. DH1 has also been engineered to utilize sucrose albeit with some issues such as very slow growth rates and high level of instability (Garcia, 1985; Bruschi et al., 2011) ). Introduction of the non-PTS (permease) utilization mechanism from E. coli W encoded by the csc regulon, overcomes these problems. Key to this success was removal of the cscR regulator from the csc regulon and, most critically, introduction in single copy onto the chromosome to avoid severe toxicity and instability which results from plasmidmediated expression. This approach allows K-12 MG1655, B and C strains to grow at the same rate on sucrose as they do on glucose (Bruschi et al., 2011) . Engineering sucrose utilization using the cscAKB operon would bring DH1 even closer to industrial application.
In contrast, there is a paucity of publications addressing the metabolic engineering of chromosomally integrated production pathways, especially for the MVA pathway in E. coli.
Although the use of plasmid-based expression systems can achieve high protein levels, this presents an inherent segregational and spatial instability and often require the use of expensive antibiotics for plasmid maintenance (Friehs, 2004) . Therefore, chromosomal integration and optimization of heterologous pathways directly in the genome is an important step to generate stable and reproducible strains preferred by industry. While yeast has shown highly efficient recombination capability to easily integrate large linear pieces of DNA onto specific locations of the genome (Szostak et al., 1983) , E. coli has a lower capacity to chromosomally integrate large
This article is protected by copyright. All rights reserved DNA fragments (Jeong et al., 2013; Mosberg et al., 2010; Sawitzke et al., 2007) and this is one of the major drawbacks. This probably explains the deficiency in publications addressing chromosomal integration of large heterologous pathways, especially in recA -E. coli strains used for production (e.g. DH1).
These considerations demonstrate that the ability to grow on sucrose and the expression of the heterologous pathway genes from the host chromosome under the control of self-regulated promoters are important features to implement in E. coli for industrial applications. Here, we report on approaches to engineer E. coli DH1 as a potential industrial host for the production of isoprenoid-based biofuels. We use a transferable cscAKB operon to confer capacity to efficiently grow on sucrose (Bruschi et al., 2011) , chromosomally integrate the heterologous MVA pathway controlled by stress responsive regulation for the production of bisabolene, and develop a new engineering approach using CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and its associated Cas9 endonuclease) to add/replace T7 promoters (PT7) of different strength directly onto the chromosome. Finally, we report the challenges associated with this new engineering approach on the chromosome and propose future directions for complex pathway optimization in E. coli.
Results
Generation of an E. coli DH1 strain able to grow and produce bisabolene from sucrose
To engineer bisabolene production from sucrose as a carbon source, there are two options: either express an isoprenoid pathway in naturally occurring sucrose-utilizing E. coli strain such as W (Archer et al., 2011) or integrate the sucrose utilization genes into a strain previously engineered for the production of isoprenoids, such is DH1. We first explored the
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This article is protected by copyright. All rights reserved former option and transformed plasmids expressing the MVA pathway for the production of bisabolene into the natural sucrose utilizer E. coli W. However, the cells grew poorly and did not produce bisabolene at detectable levels (data not shown), suggesting there is an intrinsic problem with the expression of the MVA pathway genes in this host strain. Thus, we attempted the second option and transferred the sucrose utilizing capability from E. coli W into DH1. As previously described (Bruschi et al., 2011) , the sucrose utilizing operon (cscAKB) from W strain was integrated into the DH1 chromosome at the arsB locus using 'knock-in/knock-out (KIKO)' plasmid vectors (Figure 1 ), designed to successfully integrate large pieces of DNA into different locations of the E. coli chromosome (Sabri et al., 2013) . After the cscAKB operon was recombined onto the chromosome (under the control of its native constitutive promoter), a new strain (DS) was generated. DS and its derivatives were able to grow on sucrose to ODs comparable to, or sometimes even higher than those on glucose ( Figure 2b ).
DS strain harboring the best combination of plasmids reported for bisabolene production (JPUB_002475 + JPUB_002466, Table 1 ) yielded ~1 g/L of bisabolene using either sucrose or glucose ( Figure 2a ). Under the same conditions, the DH1 strain produced approximately the same amount of bisabolene from glucose as DS, but it only showed residual growth and production of bisabolene when grown on sucrose (Figure 2a, b) , confirming the successfully transferred sucrose utilization capability in DS strain.
Inducer-free, dynamic-controlled production of bisabolene from sucrose
Strain DS was transformed with plasmid pBbA0c-PgadE-MevT-MBIS (JBEI-2872, Table   1 ) that provides MVA pathway enzymes to synthesize farnesyl diphosphate (FPP) under the control of FPP-responsive gadE promoter (PgadE) (Dahl et al., 2013) . RstA promoter (PrstA) is known to be up-regulated in the presence of FPP and used to control the terpene synthase
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This article is protected by copyright. All rights reserved expression that consumes FPP, but its strength was too weak to efficiently express the terpene synthase and showed lower terpene production level than the strain with the terpene synthase under a stronger promoter (trc promoter, Ptrc) (Dahl et al., 2013) . We tried both combinations in DS strain using either glucose or sucrose as a carbon source, and surprisingly, the DS strain harboring pJBEI-2872 and pRstA-BIS, a complete dynamic system, gave a higher production (~850 mg/L; Figure 2c , d) when grown in sucrose over glucose.
Initial attempts for chromosomal integration of a self-regulated MVA pathway
We chose the MVA pathway genes for chromosomal integration from the system previously shown to have the highest bisabolene yields in E. coli .
The construct containing all genes in the pathway is over 10Kb and exceeds the optimal size for successful λ-red based integration (~2Kb) (Kuhlman and Cox, 2010). Although we successfully integrated the sucrose operon (~4Kb) into the E. coli DH1 genome using KIKO vectors, the low recombination efficiency in E. coli DH1 (Hanahan, 1983) made this simple integration a difficult task even with the aid of well-established recombinases (Datsenko and Wanner, 2000; Jeong et al., 2013) . We attempted to integrate the entire pathway including the terpene synthase (~12 Kb) into the DH1 chromosome using a more efficient methodology based on suicide plasmids that would recombine into the genome by a single cross-over (Haldimann and Wanner, 2001; Sabri et al., 2013) . Nevertheless, we could not get any colonies with the correct integration using this method. The large size of the pathway genes and the complexity associated with the pathway (Pitera et al., 2007) seem to be the most plausible explanation for these unsuccessful attempts.
Therefore, we decided to split the pathway into three operons shorter than 5Kb and integrate them in three different locations in the genome ( Figure 3 ). With this approach we intended not
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This article is protected by copyright. All rights reserved only to integrate the whole pathway but also to provide a way to achieve the optimal expression ratio among the three operons for the best production (Alonso- .
MVA pathway splitting and integration at different chromosomal locations
The MVA pathway was split into three operons as previously described (AlonsoGutierrez et al., 2015) ( Figures 3 and 4) . DNA parts were collected from previously published BglBrick plasmids (Table 1 ) and assembled together into KIKO vectors to integrate the operons for modules: T (pKIKO-Cm-poxB-PgadE-MevT), M (pKIKO-Kan-lacZ-Ptrc-MevB) and B
(pKIKO-Kan-rbsAR-LacI-Ptrc-BS-idi-ispA) of the pathway ( Figure 1 , Table 1 ). Module T includes the MevT operon to transform acetyl-CoA into MVA (Table 1 ) under the control of the FPP-responsive promoter PgadE , which provides dynamic control of pathway expression (Dahl et al., 2013) . Modules M and B contain codon optimized genes for the optimal expression of enzymes transforming MVA into isopentenyl pyrophosphate (IPP) (MevB operon) and IPP into bisabolene, respectively, under IPTG-inducible Ptrc promoters (Table 1) . Even though PrstA would be necessary to provide complete dynamic regulation in combination with PgadE, we anticipated that the low transcription rate of PrstA (Dahl et al., 2013) would not be enough to provide the necessary enzyme levels of the bisabolene synthase once integrated and therefore we decided to use Ptrc.
From our previous work in engineering the MVA pathway, the ideal relative expression ratio among MVA pathway modules was determined as B > M > T ( Alonso-Gutierrez et al., 2015) . We used different combinations of plasmid copy number and promoter strength in this work, but the chromosomally integrated system does not allow as many levels of expression control as plasmid-based system does. It is reported that chromosomal location can markedly influence the level of expression of integrated genes (Bryant et al., 2014) , which is also observed
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This article is protected by copyright. All rights reserved using KIKO vectors (Sabri et al, 2013) , and therefore, we placed the different portions of the pathway at distinct locations of the E. coli genome known to have different expression levels to achieve this ratio. Three loci (rbsAR, lacZ, and poxB) were selected based on the reports that expression levels decreased with distance from the genomic origin of replication (Bryant et al., 2014; Sabri et al., 2013) , and we integrated three modules (B, M and T) at these locations respectively. We selected poxB locus to achieve additional benefit of reducing carbon loss by acetate formation as previously reported (Goh et al., 2014) . To avoid potential toxicity problems by prenyl diphosphate accumulation (Dahl et al., 2013; George et al., 2014) , we carefully designed the order of integration. Module M was integrated first, considering that the MevB operon would not produce any toxic intermediate by itself in the absence of module T (i.e.
without MVA). We integrated module B next, and finally module T to produce MVA as shown in Figure 2 .
After integrating every portion of the pathway, a new strain (named DSTMB or DK1) was generated (Table 2, Figure 4 ). This strain grew to an OD similar to that of the wild-type and produced ~77 and ~138 µg/L of bisabolene with glucose and sucrose as carbon source, respectively ( Figure 6 ). These titers, however, were significantly lower than those from plasmidbased system. Therefore, we investigated why such a low production level was achieved from the integrated system, and explored novel approaches to optimize the integrated pathway.
Optimization of chromosomally integrated pathway using CRISPR-Cas9 based approach.
Plasmid-based pathway expression provides multiple copies of each gene. In contrast, when integrated onto the chromosome only one copy of each gene is responsible for the expression of the corresponding enzyme required for production. Therefore, the first hypothesis to account for the lower production level is that a single copy of pathway gene could not provide
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Bacteriophage T7 RNA polymerase (T7RNAP), a highly processive single subunit RNA polymerase (RNAP), and its associated promoters (PT7) have been successfully used to achieve high expression levels of heterologous enzymes (Koma et al., 2012; Temme et al., 2012b; Wang et al., 2012) . T7RNAP has a much higher transcriptional capability than the cell's native RNAP, allowing for high expression levels even from a single gene (Studier and Moffatt, 1986) , and it has been reported that the protein levels achieved from a single chromosomal copy under PT7 can be comparable to those achieved from a plasmid-based expression system (Koma et al., 2012 ).
Since PT7 is not responsive to the native host RNAP and slight variations in its sequence translate into different transcriptional strength, using PT7 provides a completely orthogonal and tunable control of expression (Temme et al., 2012a) . T7RNAP was transduced into strain DSTMB genome between genes ybhB and ybhC generating strain DSTMB7 (or DK4; Table 2; Figure 5 ).
Integration was validated both by colony PCR (primer sequences in Supplementary Table S1) and by checking the presence of plaques after infection with a T7RNAP dependent phage. Strain DK4 was confirmed to contain the csc operon, the whole MVA pathway and a functional T7RNAP integrated on the chromosome (Table 2 and Figures 3 and 4) . The promoters driving the integrated MVA pathway in DK4 were sequentially replaced by PT7 using λ-red mediated integration and CRISPR-Cas9 selection of the recombinant strains ( Figure 5 ) with the goal to achieve higher transcriptional rates, overall enzyme expression, and ultimately product titers. We chose wild type PT7 for modules M and B, which are known to require higher levels of expression, while we used "PT7.2_P2" (part number SBa_000445 (Temme et al., 2012) ) for the
This article is protected by copyright. All rights reserved expression of the module T, which is known to require lower expression levels relative to the rest of the operons.
As explained in Figure 4 , the CRISPR system used in this work consists of two plasmids (pSMR77 and either pMCC or pMCK depending on the resistance marker). pSMR77, which provides both the λ-red protein and the Cas9 protein, was first transformed into DK4 to generate strain DK15 ( Figure 5 ). By keeping carbenicillin in the medium and the temperature below 30°C, this plasmid was maintained during iterative rounds of modification. Both pMCC and pMCK express the guide RNA to target specific sequences in the E. coli genome to be cut by Table 1 ) to remove the protospacers and to integrate a PT7 sequence in its place (Figure 4 ). At each of these locations, the originally integrated weak promoters (and its associated protospacer sequences) were substituted to stronger PT7 responding to T7RNAP
( Figure 5 ).
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To generate strain DK2, DK15 was first transformed with pMCC-gCrB-B' and a fixing template fixB to introduce PT7 in module B. DK2 was subsequently electroporated with pMCKgCrM-M' and fixM to generate DK28, a strain with both modules M and B under PT7 control.
However, the co-transformation of pMCC-gCrT-T' and fixT in DK28 did not generate any colony with the correct PT7 substitution at the module M. As an alternative, we tried to generate a triple substitution first by replacing module T promoter in DK15 using the same combination of crRNA and fixing template (pMCK-gCrT-T' and fixT). This time we got colonies after the CRISPR screening and generated strain DK16, in which PT7 drives only module T. This verifies that the CRISPR system for module T works and suggests that the previous failure in DK28
could be related to potential imbalance of protein expression among three operons, which might result in the accumulation of toxic intermediates. DK16 was further engineered into strain DK29
where PT7 drives both modules T and B. However, DK29 was unable to accept the third change (a replacement of the Ptrc by a PT7 to drive module M) once again. Finally, we tried the third route by substituting Ptrc by PT7 in module M of DK15. DK24 was generated in this way, but once again, substitution of module T did not work, reinforcing the hypothesis of pathway imbalance.
Strain DK16, in which a PT7 drives module T (fixT incorporated to DK4; Table 2, Figure   4 ) and its descendent, DK29 (fixB incorporated on DK16 and therefore with PT7 driving both modules T and B) experienced increase in bisabolene production compared to its predecessor DK4. DK16 produced ~200 µg/L and ~300 µg/L of bisabolene when cultured with glucose and sucrose, respectively, representing a ~2.5-fold increase in production compared to DK4, and DK29 produced ~435 µg/L of bisabolene using both carbon sources, representing a ~4-fold increase compared to DK4 (Figure 6 ). However, any of the other strains with PT7 driving either
This article is protected by copyright. All rights reserved module M (DK24), module B (DK2) or both M and B modules (DK28) ( Table 2 ) experienced a ~2.5-fold decrease in production compared to DK4 (Figure 6 ). More interestingly, neither the combination of T and M modules changes (e.g., fixT+fixM) nor the replacement of all promoters could be achieved in any order, and we could not see any colonies from these experiments.
Rather than a problem with our CRISPR system, this suggests a toxicity issue from unbalanced expression of the MVA pathway since every one of these changes could be individually achieved in different strain background.
Proteomics-aided diagnosis and promoter replacement for optimization.
In this work, to achieve better understanding on the nature of the genomic changes, to pinpoint potential bottlenecks, and to inform better engineering strategies, we integrated the heterologous pathway directly into the chromosome and modulated pathway expression by changing parts such as promoters. Proteomic analysis of the first iteration, with the same promoters (Ptrc and PgadE) as the plasmid-based system, revealed that the pathway enzyme level from the chromosome was significantly lower (on average, 10-fold lower) than what was achieved in the plasmid system (Table 3) . To overcome any transcriptional limitation, we replaced those promoters with PT7 and the expression levels of the module T enzymes responded as expected. The expression level for the first two enzymes in the operon (AtoB and HMGS) dramatically increased in strain DK29, and comparable to the levels of those enzymes achieved from plasmid-based systems (Table 3) . However, the third gene in the operon (HMGR) showed lower expression levels than that in the DK4 strain. More interestingly, the proteomic analysis revealed that the fixing template we used to fix module B did not result in a higher level for any of the enzymes in the operon but rather a decrease. This could bring some issues on the efficiency of the PT7-RBS sequence we used. In addition, module M also showed unexpected
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This article is protected by copyright. All rights reserved behavior. The replacement of the promoter from Ptrc to PT7 did not improve the levels of the first two enzymes while the level of PMD (the third and last enzyme of the operon) was increased (Table 3) . A more systematic approach, beyond the scope of this work, on various components such as integration location, promoter selection, RBS selection, and the distance between the promoter and RBS will provide better understanding of the protein expression from the chromosomal system and enable more accurate design of the system for chromosomal metabolic engineering.
Discussion
In this report, we addressed several approaches to improve E. coli as a host for industrial production of isoprenoid-based biofuels. Even though some E. coli strains such as the W strain can grow on sucrose (Archer et al., 2011) , integration of the MVA pathway was not successful.
The growth phenotype of the W strain suggests a stress response to the expression of the MVA pathway, which might have triggered the host's natural recombination machinery against the pathway on the plasmids, but it still need more evidence to conclude so.
Although the chromosomal integration was successful at each of the three locations in the E. coli DH1 genome, the overall production levels from the integrated strains were significantly lower than those from plasmid-based systems. With the rare exception of AtoB, the proteomic analysis showed very low protein expression for the integrated pathway genes (only about 10% of what is detected from plasmid-based system; Table 3 ). This is not surprising since there is only one copy of each gene in the chromosome while multiple copies are available in plasmidbased systems. To address this, there was an effort to multiply the copies of the integrated pathway genes using antibiotic stress (Tyo et al., 2009 ). However, the production level was still
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This article is protected by copyright. All rights reserved not comparable to those from the plasmid-based system, and furthermore, the repeated copies of antibiotic marker in the chromosome could pose safety concerns associated with the use of antibiotic resistance markers in a bioreactor that could be spread by horizontal gene transfer into the environment (Hiltunen et al., 2017; Robinson et al., 2016) .
E. coli natively corrects defective protein levels by varying the promoter sequence rather than mutating or duplicating coding genes (Amorós-Moya et al., 2010) . In this work, we attempted to emulate this natural strategy by replacing the promoters in strain DSTMB instead of refactoring or adding extra copies of the pathway genes. All the promoters used in strain DSTMB for heterologous gene expression respond to E. coli's native RNAP. However, these promoters are rather weak and therefore we had to substitute them with stronger promoters such as PT7, in the presence of T7RNAP, and further optimized the integrated pathway by engineering regulatory sequences such as promoters and RBSs using CRISPR-Cas9 approach which allows a rapid, scar-less and multiplex edition of E. coli genome with high efficiency Jiang et al., 2015; Li et al., 2015) .
As described in the results section, we replaced promoters individually at each of the three locations with PT7 and improved bisabolene production from sucrose up to 4-fold when both modules T and B were overexpressed under PT7. However, the simultaneous replacement of all three promoters by PT7 was not successful in any combination. This suggests that there could be an intrinsic issue of unbalanced protein expression, which precludes the system from further optimization.
Even though we thoroughly investigated the best relative locations for the integration of each of the three operons based on previous literature, the proteomic analysis of the strain DSTMB showed that the relative enzyme expression levels were far from the optimal ratio
This article is protected by copyright. All rights reserved achieved on plasmid-based systems . The rbsAR locus was previously reported to allow higher expression levels than lacZ and poxB loci (Sabri et al., 2013) , and therefore we chose it for the expression of module B of the pathway to achieve the highest expression level among three modules . However, the overall levels of module B proteins turned out to be the lowest even after we replaced its promoter to PT7
as shown in Table 3 . There are many factors known to influence the level of expression including chromosomal location, directionality and genetic context (Block et al., 2012; Bryant et al., 2014; Reyes-Lamothe et al., 2012; Sabri et al., 2013) , and therefore, using chromosomal location by itself might not be enough to control gene expression. Our promoter replacement strategy showed some success in engineering gene expression in the chromosome. The proteomic analysis revealed that the expression level for the first two enzymes in module T substantially increased after the promoter replacement with PT7 (Table 3) . However, the replacement by PT7 in the modules M and B did not translate as expected even though we have confirmed that there were no artifacts in the proteomic analysis and the chromosomal sequence.
In this work, we originally attempted to optimize a chromosomally integrated MVA pathway by aiming to meet a specific ratio of pathway enzymes expression previously shown in the plasmid-based systems . Based on our proteomics data, however, the results were not consistent to our prediction. We could not clearly explain whether this was due to a poor choice of chromosomal location and/or promoter-RBS regulatory parts, but we expect a more systematic analysis would be helpful to elucidate these results in the future.
From the cell growth and the production levels of the genome integrated strains, we noticed that the engineering for sub-optimal enzyme levels may cause severe toxicity and cell death when performed directly in the genome, while it usually leads only to low-producing
This article is protected by copyright. All rights reserved phenotypes in plasmid-based strains. The chromosomal pathway optimization strategy based on iterative cycles of part replacements and analysis may only be able to cover limited subgroups and non-viable intermediate phenotypes could preclude identification of the optimal phenotype.
Therefore, a technique allowing multiple changes in the chromosome in a concurrent fashion would be more desired. It has been reported that CRISPR can edit up to three locations simultaneously (Jiang et al., 2015) , but many more simultaneous changes might be necessary to optimize complex metabolic pathways such as the MVA pathway. Multiplex Automated Genome Engineering (MAGE) and its subsequent improved versions (Isaacs et al., 2011; Jeong et al., 2013; Wang et al., 2009; Wang et al., 2012) enable the simultaneous change of multiple regulatory regions that translate into production improvements. PT7 consists of just 23 bp and slight variations in the promoter sequences as well as RBS sequences can provide significantly wide range of the transcription strength (Salis et al., 2009; Temme et al., 2012a) . However, MAGE requires an efficient screening system, and without a proper screening method the use of this technique will be limited. Recently, a new method called 'CRISPR Optimized MAGE Recombineering' (CRMAGE) (Ronda et al., 2016) combines CRISPR as a means of screening for strains, and this approach would be a good fit in our chromosomal engineering approach.
The development of better multiplex editing tools compatible with an automated design-buildtest-learn (DBTL) cycle would be necessary to explore such complex genetic spaces and to generate industrially relevant strains.
Finally, we envision the implementation of a dynamic control system (such as quorum sensing (e.g. Lux I/R system) or stress-responsive promoters (e.g. PgadE/PrstA)) to express T7RNAP, which would translate into an inducer-free, self-regulating system for chromosomally integrated pathways driven by PT7. The resulting strain would work free of expensive antibiotics
This article is protected by copyright. All rights reserved and inducers while having an improved stability; all of which are key features for an industrially relevant host.
Materials and Methods
All chemicals, solvents and medium components were purchased and used without modification from Sigma-Aldrich (St. Louis, MO), Fisher Scientific (Pittsburgh, PA), or VWR (West Chester, PA) unless otherwise noted. For targeted proteomics experiments, mass spectrometric-grade trypsin was obtained from Sigma-Aldrich and prepared according to manufacturer's instructions.
DNA synthesis was ordered as gBlocks through IDT (Coralville, IA). DNA concentration was estimated using Nanodrop (Thermo, Waltham, MA).
Strain construction
E. coli DH10B (Invitrogen, Carlsbad, CA) and pir+ were used as the host for cloning while E.
coli DH1 (ATCC33849) was used as the host for bisabolene production. All plasmids and strains used in this study are described in Tables 1 and 2 . MVA pathway genes were taken from the previously reported systems (Martin et al., 2003) and include different modifications that improved isoprenoid production in plasmid-based systems Dahl et al., 2013) . In order to enable rapid cloning and assembly of genes, we employed the BglBrick (Anderson et al., 2010) and Gibson (Gibson et al., 2009) cloning strategies. All plasmids denoted pBb were prepared using the BglBrick standard collection of expression vectors . Cells containing the DE3 lysogen and T7RNAP were constructed by transfection with the DE3 lysogen using the λDE3 Lysogenization Kit plus (Novagen, Darmstadt, Germany). The detail of strain construction is presented in Supplementary Method.
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Growth conditions and terpene analysis
E. coli strains harboring bisabolene production pathways were grown in 8 mL of EZ-Rich defined medium (Teknova, Hollister, CA) supplemented with 1% glucose or 1% sucrose and appropriate antibiotics in glass culture tubes. Working concentrations were 30, 50 and 100 μg/mL for chloramphenicol, kanamycin and ampicillin, respectively. Starter cultures were grown overnight at 37°C, and all samples were shaken in rotary shakers at 200 rpm (Kühner, Basel, Switzerland) . Production cultures were inoculated at an optical density (OD600 nm) of 0.1, and allowed to continue growth at 30°C, as the lower temperature improved terpene production. Each of the different strains was induced at OD600nm ~0.4 with 500 μM of isopropyl β-d-1-thiogalactopyranoside (IPTG) concentrations. Samples for both terpene production and OD600 nm production were taken at 24 and 48 hours while proteomic measurements were only performed at 24 h during late exponential phase. For production assays, a dodecane layer (10% by volume) was added to the culture upon induction to trap the terpene, and 10-100 μL of the organic phase was sampled and diluted 2-to 100-fold (depending on the final concentration in the culture) to be analyzed using gas-chromatography mass-spectrometry (GC/MS) as reported previously .
λ-Red mediated chromosomal integration of the MVA pathway
Since the pathway is much bigger (~15Kb) than the recommended DNA size for λ-Red mediated integration (~2Kb (Kuhlman and Cox, 2010)), we divided the pathway into three operons with the size of 4-5Kb and PCR-amplified them as cassettes surrounded by 500bp homology arms using KIKO vectors as templates to be independently integrated at three different locations in the DH1 genome (Sabri et al., 2013) . The detail of chromosomal integration procedure is presented in Supplementary Method.
Acce pt e d Prep rint
CRISPR-Cas9 selection protocol
We used CRISPR-Cas9 to individually substitute the promoter driving each of the three MVA pathway modules (i.e. T, M, and B) in the DSTMB7 (or DK4) with PT7. The detail of CRISPRCas9 selection protocol is presented in Supplementary Method.
Targeted proteomics
Targeted proteomics was performed as previously described , and detailed method is presented in Supplementary Method.
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This article is protected by copyright. All rights reserved into the E. coli chromosome; 1 st ) Module M was integrated at the lacZ locus; 2 nd ) The sucrose utilization operon was integrated at the arsB locus; 3 rd ) Module B was integrated at the rbsAR locus close to the origin of chromosomal replication (oriC) and therefore with likely higher
This article is protected by copyright. All rights reserved transcription activity. 4 th ) The top portion of the MVA pathway (module T) was integrated at poxB. Finally, the T7 RNA polymerase (T7RNAP) gene was transduced into the chromosome as part of the DE3 lysogen. Since E. coli is not able to produce MVA, the integration of module T as the last step avoids potential toxicity problems of intermediates that would otherwise accumulate in the absence of a complete MVA pathway. All integrations (except for the T7RNAP that was mediated by phage transduction) were done by homologous recombination between ~500 bp homology arms ("_up" and "_dw") surrounding each cassette and the chromosome. Recombinants were screened using different antibiotic markers that were subsequently removed using flippase recognition target (FRT) sites surrounding each marker to loop it out and enable reuse of the marker in subsequent engineering steps. The number of base pair next to each target loci, indicates its chromosomal location relative to the threonine (thr) locus. pyogenes. b) This crRNA guides the Cas9 protein to two regions of chromosomal DNA (# and #'). New targets can be changed by a two-piece Gibson assembly between a linearized pMCC/K plasmid using SmaI and a gBlock fragment providing the crRNA and the promoter sequence.
Co-selection of pSMR77 and either pMCC or pMCK leads to cell death unless a "fixing template" (double stranded DNA with homology to chromosomal DNA) is provided to replace the target sequences in the chromosome (protospacers)). c) Two protospacer target sites
This article is protected by copyright. All rights reserved surrounding each of the promoters controlling expression of module T (CrT/T'), module M (CrM/M') and module B (CrB/B') were selected to screen against cells which did not recombine the PT7 (fixing templates fixT, fixM and fixB respectively). AcCoa; acetyl-CoA; MVA: mevalonate; IPP: isopentenyl pyrophosphate; BIS: bisabolene. 
